Biohaven names new board chairman, CFO
The board of directors of Biohaven Pharmaceuticals recently elected CEO Vlad Coric to the role of board chairman, following the retirement of Declan Doogan. Meanwhile, Matthew Buten will...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The board of directors of Biohaven Pharmaceuticals recently elected CEO Vlad Coric to the role of board chairman, following the retirement of Declan Doogan. Meanwhile, Matthew Buten will...
The FDA issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate...
A potential treatment for agitation in patients suffering from Alzheimer’s disease is moving closer to market. New Haven-based BioXcel Therapeutics has announced the start of its Phase...
The Nasdaq Biotechnology Index now includes Guilford biotech firm Quantum-Si. The Biotechnology Index tracks the performance of a select group of biotechnology or pharmaceutical securities. Nasdaq indexed...
InveniAI® and Kyowa Kirin have expanded their longstanding relationship with a new, multiple drug discovery agreement. The collaboration will provide Kyowa Kirin with access to InveniAI’s...
Hugo Barra, formerly an executive at social-media leader Facebook and web-search giant Google, has been named chief executive officer of Detect, a Covid-19 testing startup. The company...
The Vaccine Makers Project, a program of the Vaccine Education Center at Children’s Hospital of Philadelphia (VEC@CHOP) and Medical History Pictures (MHP) partnered up again...
Pfizer reports its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed...
Harnessing the body’s immune system to treat cancer has made remarkable cures possible — but not for every patient. Researchers from UConn Health and the Cleveland Clinic...
New Haven, Conn., December 14, 2021 – Jonathan Rothberg, Ph.D., a serial entrepreneur who founded 4Catalyzer and has founded and led a number of other Connecticut bioscience initiatives, has...